Fluorine-18 fluorodopa

Approved Use: Indicated for use in PET to visualize dopaminergic nerve terminals in the striatum for the evaluation of adult patients with suspected Parkinsonian syndromes (PS). Fluorodopa F 18 PET is an adjunct to other diagnostic evaluations.
Dose: 5 mCi

Manufacturer: The Feinstein Institutes for Medical Research
Package Insert

• NDC #: 13267-345-56

​Package Insert

• NDC #: 13267-346-57

Storage: Avoid direct light

Clinical Guidelines:

• EANM Practice Guideline/SNMMI Procedure Standard for Dopaminergic Imaging in Parkinsonian Syndromes (2020)